Dana-Farber Cancer Institute presents anti-CDK9 and CDK8 proteolysis targeting chimera compounds Nov. 14, 2017
Shanghai Hansoh Biomedical, Jiangsu Hansoh Pharmaceutical Group patent IDO-1/TDO inhibitors Nov. 14, 2017